These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26314314)

  • 1. Death ligands and granulysin: mechanisms of tumor cell death induction and therapeutic opportunities.
    Martinez-Lostao L; de Miguel D; Al-Wasaby S; Gallego-Lleyda A; Anel A
    Immunotherapy; 2015; 7(8):883-2. PubMed ID: 26314314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-15-activated natural killer cells kill autologous osteoclasts via LFA-1, DNAM-1 and TRAIL, and inhibit osteoclast-mediated bone erosion in vitro.
    Feng S; Madsen SH; Viller NN; Neutzsky-Wulff AV; Geisler C; Karlsson L; Söderström K
    Immunology; 2015 Jul; 145(3):367-79. PubMed ID: 25684021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
    Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
    Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
    Arancia G; Malorni W; Donelli G
    Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased prevalence of peripheral blood granulysin-producing cytotoxic T lymphocytes in preeclampsia.
    Molvarec A; Shiozaki A; Ito M; Toldi G; Stenczer B; Szarka A; Nakashima A; Vásárhelyi B; Rigó J; Saito S
    J Reprod Immunol; 2011 Sep; 91(1-2):56-63. PubMed ID: 21763002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell death mechanisms induced by cytotoxic lymphocytes.
    Chávez-Galán L; Arenas-Del Angel MC; Zenteno E; Chávez R; Lascurain R
    Cell Mol Immunol; 2009 Feb; 6(1):15-25. PubMed ID: 19254476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulysin: The attractive side of a natural born killer.
    Sparrow E; Bodman-Smith MD
    Immunol Lett; 2020 Jan; 217():126-132. PubMed ID: 31726187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAIL is involved in the tumoricidal activity of mouse natural killer cells stimulated by Newcastle disease virus in vitro.
    Song DZ; Liang Y; Xiao Q; Yin J; Gong JL; Lai ZP; Zhang ZF; Gao LX; Fan XH
    Anat Rec (Hoboken); 2013 Oct; 296(10):1552-60. PubMed ID: 23959779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis.
    Støy S; Dige A; Sandahl TD; Laursen TL; Buus C; Hokland M; Vilstrup H
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G269-76. PubMed ID: 25501547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Do Cytotoxic Lymphocytes Kill Cancer Cells?
    Martínez-Lostao L; Anel A; Pardo J
    Clin Cancer Res; 2015 Nov; 21(22):5047-56. PubMed ID: 26567364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
    Kayagaki N; Yamaguchi N; Nakayama M; Takeda K; Akiba H; Tsutsui H; Okamura H; Nakanishi K; Okumura K; Yagita H
    J Immunol; 1999 Aug; 163(4):1906-13. PubMed ID: 10438925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-γ.
    Sarhan D; D'Arcy P; Wennerberg E; Lidén M; Hu J; Winqvist O; Rolny C; Lundqvist A
    Eur J Immunol; 2013 Jan; 43(1):249-57. PubMed ID: 22996291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A calcium optimum for cytotoxic T lymphocyte and natural killer cell cytotoxicity.
    Zhou X; Friedmann KS; Lyrmann H; Zhou Y; Schoppmeyer R; Knörck A; Mang S; Hoxha C; Angenendt A; Backes CS; Mangerich C; Zhao R; Cappello S; Schwär G; Hässig C; Neef M; Bufe B; Zufall F; Kruse K; Niemeyer BA; Lis A; Qu B; Kummerow C; Schwarz EC; Hoth M
    J Physiol; 2018 Jul; 596(14):2681-2698. PubMed ID: 29368348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.
    Kashii Y; Giorda R; Herberman RB; Whiteside TL; Vujanovic NL
    J Immunol; 1999 Nov; 163(10):5358-66. PubMed ID: 10553060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer of the CD40-ligand to human dendritic cells induces NK-mediated antitumor effects against human carcinoma cells.
    Tomihara K; Kato K; Masuta Y; Nakamura K; Tanaka T; Hiratsuka H; Hamada H
    Int J Cancer; 2007 Apr; 120(7):1491-8. PubMed ID: 17205529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of cytotoxic lymphocytes by interferon-alpha: role of oxygen radical-producing mononuclear phagocytes.
    Hansson M; Romero A; Thorén F; Hermodsson S; Hellstrand K
    J Leukoc Biol; 2004 Dec; 76(6):1207-13. PubMed ID: 15361542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 'kiss of death' by dendritic cells to cancer cells.
    Chan CW; Housseau F
    Cell Death Differ; 2008 Jan; 15(1):58-69. PubMed ID: 17948029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine regulation and tumor immunity.
    Toni R; Mirandola P; Gobbi G; Vitale M
    Eur J Histochem; 2007; 51 Suppl 1():133-8. PubMed ID: 17703604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.